Sri Lanka approves use of Anti-COVID pill Molnupiravir
Sri Lanka COVID-19 Technical Committee has granted approval for the use of oral antiviral pill ‘Molnupiravir’ in Sri Lanka.
State Minister Prof. Channa Jayasumana said that in response to his letter seeking the panel’s opinion on the usage of Molnupiravir for COVID-19 management in Sri Lanka, the committee of experts have granted approval for its use in the country.
He said that steps would be taken to register the drug in Sri Lanka and provide it to patients in the country in due time.
The tablet – Molnupiravir – is the first pill designed to treat symptomatic COVID, and it was first approved by the UK medicines regulator.
According to a UK media report, it will be given twice a day to vulnerable patients recently diagnosed with the disease in the UK.
Molnupiravir, developed by the US drug companies Merck, Sharp and Dohme (MSD), and Ridgeback Biotherapeutics, is the first antiviral medication for COVID which can be taken as a pill rather than injected or given intravenously.
The drug needs to be given within five days of symptoms developing to be most effective, reported the BBC.
Latest Headlines in Sri Lanka
- Sri Lanka’s Agriculture Minister explores opportunities to export eggs and chicken September 23, 2023
- Stability should not come at the sacrifice of values of freedom of expression: U.S. Ambassador September 23, 2023
- Sri Lanka imports test kits to detect Nipah virus September 22, 2023
- Import tax on powdered milk increased September 22, 2023
- Sri Lanka President’s robust economic development program leads to 62.1% drop in inflation – Minister September 22, 2023
